Save up -80% on Olodaterol | |||
Note: this is a drug discount program, not an insurance plan. | |||
RX BIN: 015558 | RX PCN: HT | Group ID: DDN6600 | Card Holder ID: DDN6600 |
Pharmacists and Patients support. |
2019 Price of Striverdi | |
$205.63 | 1 respimat inhaler 2.5mcg/actuation |
price without discount in nearest pharmacy. Price may vary. |
Claim your free Olodaterol discount card
We offer free Olodaterol coupons and discounts that may help you save up to 80% off the retail price in your local pharmacy. Just print your coupon! It’s ready to use and never expire. Present your manufacturer copay card in most local pharmacies to get a discount on Olodaterol every time. What are you waiting for? Claim your prescription drug card now!







Get your Prescription

It’s safe and free

Buy drugs in pharmacy

Save money each time
Olodaterol volume of distribution
The volume of distribution is high (1110 L), suggesting extensive distribution into tissue. In vitro binding of olodaterol to human plasma proteins is independent of concentration and is approximately 60%.

About RX24Drugs
2018 Statistics

Discount Cards 16,000+

Clients Benefit 29%

Total savings $4,735,080
What is Olodaterol
Olodaterol is a novel, long-acting beta2-adrenergic agonist (LABA) that exerts its pharmacological effect by binding and activating beta2-adrenergic receptors located primarily in the lungs. Beta2-adrenergic receptors are membrane-bound receptors that are normally activated by endogenous epinephrine whose signalling, via a downstream L-type calcium channel interaction, mediates smooth muscle relaxation and bronchodilation. Activation of the receptor stimulates an associated G protein which then activates adenylate cyclase, catalyzing the formation of cyclic adenosine monophosphate (cAMP) and protein kinase A (PKA). Elevation of these two molecules induces bronchodilation by relaxation of airway smooth muscles. It is by this mechanism that olodaterol is used for the treatment of chronic obstructive pulmonary disease (COPD) and the progressive airflow obstruction that is characteristic of it. Treatment with bronchodilators helps to mitigate associated symptoms such as shortness of breath, cough, and sputum production. Single doses of olodaterol have been shown to improve forced expiratory volume in 1 sec (FEV1) for 24 h in patients with COPD, allowing once daily dosing. A once-a-day treatment with a LABA has several advantages over short-acting bronchodilators and twice-daily LABAs including improved convenience and compliance and improved airflow over a 24-hour period. Despite similarities in symptoms, olodaterol is not indicated for the treatment of acute exacerbations of COPD or for the treatment of asthma.
Olodaterol mechanism of action
Olodaterol is a long-acting beta2-adrenergic agonist (LABA) that exerts its pharmacological effect by binding and activating beta2-adrenergic receptors located primarily in the lungs. Beta2-adrenergic receptors are membrane-bound receptors that are normally activated by endogenous epinephrine whose signalling, via a downstream L-type calcium channel interaction, mediates smooth muscle relaxation and bronchodilation. Activation of the receptor stimulates an associated G protein which then activates adenylate cyclase, catalyzing the formation of cyclic adenosine monophosphate (cAMP) and protein kinase A (PKA). Elevation of these two molecules induces bronchodilation by relaxation of airway smooth muscles.
Dosage forms of Olodaterol
Drug | Dosage | Quantity | Price |
Striverdi | 2.5mcg/actuation | 1 respimat inhaler | $190 |
Striverdi | 2.5mcg/actuation | 3 respimat inhalers | $567 |
Striverdi | 2.5mcg/actuation | 7 respimat inhalers | $1,322 |
Striverdi | 2.5mcg/actuation | 15 respimat inhalers | $2,831 |
Prescription Generics
false
International Brands
Inspiolto Respimat
Synonyms
Manufacturers
Boehringer Ingelheim (Canada) Ltd Ltee
CAS number
868049-49-4
UNII
VD2YSN1AFD
State
solid
Affected organisms
Indication of Olodaterol
Olodaterol is indicated for use in chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. It is not indicated for the treatment of acute exacerbations of COPD or for the treatment of asthma.
Toxicity of Olodaterol
Adverse drug reactions that occurred at a frequency greater than 2% include nasopharyngitis (11.3%), upper respiratory tract infection (8.2%), bronchitis (4.7%), urinary tract infection (2.5%), cough (4.2%), dizziness (2.3%), rash (2.2%), diarrhea (2.9%), back pain (3.5%), and arthralgia (2.1%).
RX24 Drugs Disclaimer: consult your healthcare provider before buying a Olodaterol on prescription or using an RX manufacturer savings coupon. Content on this page is provided for informational purposes only. Any use of this information is at your own risk.